Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature

Abstract Dupilumab is currently the only biologic treatment approved for moderate-to-severe atopic dermatitis. Though limited, available clinical data describing dupilumab use in pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal ou...

Full description

Saved in:

Bibliographic Details
Published in:	Case reports in dermatology Vol. 13; no. 2; pp. 248 - 256
Main Authors:	Lobo, Yolanka, Lee, Ruby C., Spelman, Lynda
Format:	Journal Article
Language:	English
Published:	Basel, Switzerland S. Karger AG 01.05.2021 Karger Publishers
Subjects:	Antibodies atopic dermatitis Birth defects Breastfeeding & lactation Case and Review Case reports Dermatitis Drug dosages dupilumab Eczema Fetuses Gastroenterology Immunoglobulins Inflammatory bowel disease Light therapy Miscarriage Monoclonal antibodies Patients Pregnancy Quality of life Steroids Womens health Pregnancy Atopic dermatitis Dupilumab
ISSN:	1662-6567, 1662-6567
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!